Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
HOBDEN ADRIAN N
Pres. Myriad Pharmaceuticals at MYRIAD GENETICS. Filing since 3 Jan 2007.
CIK 0001191076
Company
Date
Role
Action
Shares
Amount
Of holding
MYGN
MYRIAD GENETICS INC
27 May 2009
Pres. Myriad Pharmaceuticals
Sold, plan not stated
40,000
$1.36M
17.0%
MYGN
MYRIAD GENETICS INC
5 Feb 2009
Pres. Myriad Pharmaceuticals
Sold, plan not stated
24,000
$2.01M
21.2%
MYGN
MYRIAD GENETICS INC
11 Dec 2008
Pres. Myriad Pharmaceuticals
Sold, plan not stated
20,000
$1.21M
18.4%
MYGN
MYRIAD GENETICS INC
25 Sep 2008
Pres. Myriad Pharmaceuticals
Sold, plan not stated
15,000
$1.03M
18.1%
MYGN
MYRIAD GENETICS INC
19 Sep 2008
Pres. Myriad Pharmaceuticals
Sold, plan not stated
992
$65.47K
1.3%
MYGN
MYRIAD GENETICS INC
17 Sep 2008
Pres. Myriad Pharmaceuticals
Sold, plan not stated
500
$33.25K
0.8%
MYGN
MYRIAD GENETICS INC
25 Aug 2008
Pres. Myriad Pharmaceuticals
Sold, plan not stated
27,464
$1.79M
30.4%
MYGN
MYRIAD GENETICS INC
25 Sep 2007
Pres. Myriad Pharmaceuticals
Sold, plan not stated
20,000
$1.00M
29.7%
MYGN
MYRIAD GENETICS INC
23 May 2007
Pres. Myriad Pharmaceuticals
Sold, plan not stated
10,000
$400.00K
17.6%
MYGN
MYRIAD GENETICS INC
3 Jan 2007
Pres. Myriad Pharmaceuticals
Sold, plan not stated
5,000
$160.00K
9.7%
10 decisions on file.
